Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/thoraxjnl-2011-201524 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Congenital Heart Defects (CHDs) are the most common congenital anomalies, affecting between 4 and 75 per 1000 live births. Cardiovascular patches (CVPs) are frequently used as part of the surgical armamentarium to reconstruct cardiovascular structures to correct CHDs in pediatric patients. This review aims to evaluate the history of cardiovascular patches, currently available options, clinical applications, and important features of these patches.
View Article and Find Full Text PDFA Practical Clinical Approach to Navigate Pulmonary Embolism Management: A Primer and Narrative Review of the Evolving Landscape.
J Clin Med
December 2024
Section of Cardiology, Cardiology Division, NYU Langone Health and NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA.
Advances in imaging, pharmacological, and procedural technologies have rapidly expanded the care of pulmonary embolism. Earlier, more accurate identification and quantification has enhanced risk stratification across the spectrum of the disease process, with a number of clinical tools available to prognosticate outcomes and guide treatment. Direct oral anticoagulants have enabled a consistent and more convenient long-term therapeutic option, with a greater shift toward outpatient treatment for a select group of low-risk patients.
View Article and Find Full Text PDFNew Immunosuppressants in Pediatric Kidney Transplantation: What's in the Pipeline for Kids?
Pediatr Transplant
February 2025
Department of Medicine III, Medical University of Vienna, Vienna, Austria.
The 1- and 5-year patient and graft survival rates of pediatric kidney transplant recipients have improved considerably in recent years. Regardless of early success, kidney transplantation is challenged by suboptimal long-term allograft and patient survival. Many kidney transplants are lost due to immune (rejection) and nonimmune allograft injuries, and patient survival is limited from cardiovascular disease, infection, and malignancy.
View Article and Find Full Text PDFThe pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood-brain barrier protection.
Mol Med
December 2024
Stroke Center, Department of Neurology, The First Hospital of Jilin University, Xinmin Street 1#, Changchun, 130021, China.
The blood-brain barrier (BBB) is the most central component of the neurovascular unit (NVU) and is crucial for the maintenance of the internal environment of the central nervous system and the regulation of homeostasis. A multitude of neuroprotective agents have been developed to exert neuroprotective effects and improve the prognosis of patients with ischemic stroke. These agents have been designed to maintain integrity and promote BBB repair.
View Article and Find Full Text PDFAddressing complications of large bore access in endovascular and cardiovascular procedures: An illustration of treatment options.
Vascular
December 2024
Division of Cardiology and Interventional Cardiology, MedStar Health: Heart and Vascular Institute at MedStar Washington Hospital Center, Washington, DC, USA.
Article Synopsis
- Endovascular procedures like TAVR, TEVAR, and EVAR are becoming more common but still carry risks, especially for older and frail patients.
- This paper discusses two cases where complications arose from large bore access during such procedures and the innovative methods used to manage them.
- The insights gained from these cases provide valuable guidance for clinicians facing similar challenges in future interventions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!